Français
ItalianoBond Royalty Pharma 5.4% ( US78081BAR42 ) in USD
| Issuer | Royalty Pharma | ||||||||||
| Market price |  97.93 % ▼ |
||||||||||
| Country |  United States
|
||||||||||
| ISIN code |
 US78081BAR42 ( in USD )
|
||||||||||
| Interest rate | 5.4% per year ( payment 2 times a year) | ||||||||||
| Maturity | 02/09/2034 | ||||||||||
|
Prospectus brochure in PDF format |
|||||||||||
| Minimal amount | 2 000 USD | ||||||||||
| Total amount | 500 000 000 USD | ||||||||||
| Cusip | 78081BAR4 | ||||||||||
| Standard & Poor's ( S&P ) rating | BBB- ( Lower medium grade - Investment-grade ) | ||||||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||||||
| Next Coupon | 02/03/2027 ( In 167 days ) | ||||||||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. A detailed analysis of a specific debt instrument reveals the characteristics of a bond issued by Royalty Pharma, a prominent funder of innovation in the biopharmaceutical industry that acquires pharmaceutical royalties and future royalty streams, providing capital to pharmaceutical and biotechnology companies. This particular bond, identified by ISIN US78081BAR42 and CUSIP 78081BAR4, was issued in the United States and is currently trading at 99.633% of its par value. Denominated in USD, the bond carries a fixed annual interest rate (coupon) of 5.4%, with interest payments distributed semi-annually, and represents a total issuance size of $500,000,000, available for purchase with a minimum allocation of $2,000. Investors should note its maturity date is September 2, 2034, and in terms of credit quality, the bond holds investment-grade ratings from major agencies, specifically BBB- from Standard & Poor's (S&P) and Baa2 from Moody's. |
||||||||||
| |||||||||||